Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Kineta divulges antivirals

April 29, 2016

Janssen submits NDA to FDA seeking approval of mebendazole chewable tablet

April 29, 2016

NVR-3-778 well tolerated and reduces HBV DNA in phase Ib trial

April 29, 2016

Laninamivir octanoate effective and well tolerated as post-exposure prophylaxis for influenza

April 29, 2016

Humabs Biomed describes novel monoclonal antibody for treating hepatitis B virus infection

April 29, 2016

FDA extends PDUFA date for Heplisav-B BLA

April 28, 2016

Pneumococcal infection model reveals protective effects of B-cell epitopes

April 28, 2016

GlaxoSmithKline and Anacor Pharmaceuticals exploit novel mechanism for treating tuberculosis

April 28, 2016

Sun Pharma and partners establish malaria elimination demonstration project

April 27, 2016

hVIVO and SEEK in joint venture investment to develop vaccines against influenza and flu

April 27, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...